QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:IMVT

Immunovant Insider Trades

$7.99
+0.34 (+4.44%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.73
$8.08
50-Day Range
$7.53
$9.32
52-Week Range
$6.68
$53.61
Volume
525,474 shs
Average Volume
1.11 million shs
Market Capitalization
$918.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.67

Immunovant (NASDAQ:IMVT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.90%

Number Of
Insiders Buying
(Last 12 Months)
3

Amount Of
Insider Buying
(Last 12 Months)
$243.81 K

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get IMVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immunovant stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Immunovant (NASDAQ IMVT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2021Douglas J HughesDirectorBuy18,247$8.24$150,355.28  
8/20/2021George V MigauskyDirectorBuy7,000$7.65$53,550.00  
8/13/2021Atul PandeDirectorBuy5,000$7.98$39,900.00  
9/11/2020Julia G ButchkoInsiderBuy5,000$38.17$190,850.005,000  
9/4/2020Sciences Ltd. RoivantMajor ShareholderBuy380,000$33.00$12,540,000.0047,593,419  
(Data available from 1/1/2013 forward)












Immunovant (NASDAQ:IMVT) Insider Trade Frequently Asked Questions

Who is on Immunovant's Insider Roster?

The list of insiders at Immunovant includes Atul Pande, Douglas J Hughes, George V Migausky, Julia G Butchko, and Sciences Ltd. Roivant.Learn more on IMVT's insiders

What percentage of Immunovant stock is owned by insiders?

1.90% of Immunovant stock is owned by insiders. Learn more on IMVT's insider holdings

Which Immunovant insiders have been buying company stock?

The following insiders have purchased Immunovant stock in the last 24 months: Atul Pande ($39,900.00), Douglas J Hughes ($150,355.28), George V Migausky ($53,550.00), Julia G Butchko ($190,850.00), and Sciences Ltd. Roivant ($12,540,000.00).

How much insider buying is happening at Immunovant?

Insiders have purchased a total of 415,247 Immunovant shares in the last 24 months for a total of $12,974,655.28 bought.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.